NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Gujarat Inject (Kerala) Ltd. : .Q4 .2024 .Quarterly Earnings: .QoQ Up .2408.8. %

May 11, 2024May 11, 2024| adminadmin| 0 Comments| 10:25 am
Image is loading
Categories:

Share the post "Gujarat Inject (Kerala) Ltd. : .Q4 .2024 .Quarterly Earnings: .QoQ Up .2408.8. %"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: substantial increase in net sales/revenue by 2408.8 %.
  • Income over the Year and quarter:
  • Profit over the Year and quarter: Significant improvement in profitability for Gujarat Inject (Kerala) Ltd.. Notable increase of 533.33 % in net profit Year to Year, Gujarat Inject (Kerala) Ltd.’s profitability increased by 660 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 200.00 % Year to Year. EPS increased by 200 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Gujarat Inject (Kerala) Ltd.”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 0.014 Cr Rs. 0.216 Cr Rs. 5.419 Cr + 2408.8 % + 386971.43 %
Expenses Rs. 0.02 Cr Rs. 0.25 Cr Rs. 5.37 Cr + 2048 % + 26750 %
Operating Profit Rs. -0.01 Cr Rs. -0.03 Cr Rs. 0.05 Cr + 266.67 % + 600 %
OPM % -71.43 % -13.89 % 0.92 % + 14.81 % + 72.35 %
Other Income Rs. 0.03 Cr Rs. 0.04 Cr Rs. 0 Cr 0 % 0 %
Interest Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Depreciation Rs. 0 Cr Rs. 0 Cr Rs. 0 Cr 0 % 0 %
Profit before tax Rs. 0.02 Cr Rs. 0.01 Cr Rs. 0.05 Cr + 400 % + 150 %
Tax % 25 % 33.33 % 15.22 % -18.11 % -9.78 %
Net Profit Rs. 0.01 Cr Rs. 0.01 Cr Rs. 0.04 Cr + 300 % + 300 %
EPS in Rs Rs. 0.01 Rs. 0.01 Rs. 0.03 + 200 % + 200 %


Today, we’re looking at Gujarat Inject (Kerala) Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 386971.43 %. However, it did see a marginal increase of 2408.8 % from the previous quarter. Expenses ticked up slightly by 2048 % quarter-on-quarter, aligning with the annual rise of 26750 %. Operating profit, while up 600 % compared to last year, faced a quarter-on-quarter increase of 266.67 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 72.35 %, but an expansion of 14.81 % sequentially. Profit before tax grew annually by 150 % but saw an increase from the preceding quarter by 400 %.
Tax expenses as a percentage of profits decreased slightly by -9.78 % compared to last year, with a more notable quarter-on-quarter decrease of -18.11 %. Net profit rose by 300 % year-on-year but experienced a 300 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 200 % but a quarterly rise of 200 %. In summary, Gujarat Inject (Kerala) Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 0.014 Cr Rs. 0.216 Cr Rs. 5.419 Cr + 2408.8 % + 386971.43 %
Expenses Rs. 0.02 Cr Rs. 0.25 Cr Rs. 5.37 Cr + 2048 % + 26750 %
Operating Profit Rs. -0.01 Cr Rs. -0.03 Cr Rs. 0.05 Cr + 266.67 % + 600 %
Net Profit Rs. 0.01 Cr Rs. 0.01 Cr Rs. 0.04 Cr + 300 % + 300 %
EPS in Rs Rs. 0.01 Rs. 0.01 Rs. 0.03 + 200 % + 200 %


In reviewing Gujarat Inject (Kerala) Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 386971.43 % year-on-year growth, however, there was a minor increase of 2408.8 % from the previous quarter. Expenses rose by 26750 % compared to the previous year, with a 2048 % increase quarter-on-quarter. Operating Profit surged by 600 % annually, and saw a 266.67 % increase from the last quarter.
Net Profit showed yearly increase of 300 %, and experienced a 300 % increase from the previous quarter. Earnings Per Share (EPS) rose by 200 % annually, however rose by 200 % compared to the last quarter. In essence, while Gujarat Inject (Kerala) Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Gujarat Inject (Kerala) Ltd. “]

Related Post